mycifradin
Mycifradin (Neomycin Sulfate) is an aminoglycoside antibacterial used to treat Escherichia Coli Infections, Hepatic Encephalopathy, Bacterial Skin Diseases.
Neomycin Sulfate · by Pharmacia and Upjohn
Key facts
- Active ingredient
- Neomycin Sulfate
- Drug class
- Aminoglycoside Antibacterial
- Form
- Tablet, Solution
- Strength
- Neomycin Sulfate EQ 350MG Base
- Type
- Prescription (Rx)
- Brand or generic
- Generic
- Manufacturer
- Pharmacia and Upjohn
- What the pharmacy pays
- ~$25.36 for 30 — not your price
- FDA application
- ANDA060520
- Availability
- Discontinued (per FDA)
Drug class
How this class works, per Aminoglycosides - StatPearls - NCBI Bookshelf.
May treat (source: NIH RxClass)
See how Mycifradin ranks — best-rated aminoglycoside antibacterial for:
Dosage forms
Tablet and Solution
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Mycifradin treat?
- Mycifradin (Neomycin Sulfate) may be used to treat escherichia coli infections, hepatic encephalopathy, bacterial skin diseases, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How does Mycifradin work?
- Mycifradin is a aminoglycoside antibacterial. Aminoglycosides kill bacteria by latching onto the germ's protein-making machinery (the 30S ribosomal subunit). This jams and misreads the bacterial genetic code so the microbe builds faulty proteins it can't survive on, which is why these drugs destroy the bacteria rather than just stopping their growth.
- How much does Mycifradin cost?
- Nobody can tell you what you will pay — your price is set by your insurer's formulary, your deductible and the pharmacy's markup, and none of those are published. What IS published is what the pharmacy paid to acquire it: about $25.36 for 30, per the CMS NADAC survey. Treat that as the floor, not the quote — ask the pharmacist for the cash price as well as your copay, because for cheap generics the cash price often wins.
- Is there a coupon or discount for Mycifradin?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Mycifradin. To pay less, Mycifradin is already a generic — usually the lowest-cost version — so the main levers are comparing cash prices between pharmacies and using a pharmacy discount-card service. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Mycifradin?
- Mycifradin is marketed by Pharmacia and Upjohn. You can see Pharmacia and Upjohn's full profile, rating, and other products on pharmaranks.
- Is Mycifradin a brand-name or generic drug?
- Mycifradin is a generic medication; its active ingredient is Neomycin Sulfate. Generics contain the same active ingredient as the brand-name original and are usually lower cost.
- Is Mycifradin available over the counter?
- No. Mycifradin is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Mycifradin come in?
- Mycifradin is currently marketed as tablet and solution, per the FDA's National Drug Code Directory.
- What class of drug is Mycifradin?
- Mycifradin is classified as aminoglycoside antibacterial, per the FDA's Established Pharmacologic Class.
- Is Mycifradin FDA-registered?
- Mycifradin is on record with the U.S. FDA under application number ANDA060520. You can verify this on its official FDA label.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
Reviews
No reviews yet. Be the first to write one.
People also viewed
bethkis
Tobramycin
gentamicin sulfate
Gentamicin Sulfate
tobi
Tobramycin
tobi podhaler
Tobramycin
tobrex
Tobramycin
neomycin sulfate
Neomycin Sulfate
Compare Mycifradin head-to-head
More aminoglycoside antibacterial drugs
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
mycifradin
New